Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgery

(MedPage Today) -- An investigational genomic assay may be able to identify women who don't stand to benefit from adjuvant radiation therapy (RT) following breast-conserving surgery, researchers reported. Using tumor samples from a completed phase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news